COVID-19 in patients with glomerular disease.

Tabitha Turner-Stokes,Helena Edwards,Liz Lightstone

Current opinion in nephrology and hypertension（2021）

引用 0|浏览2

暂无评分

摘要

Patients with glomerular disease represent an at-risk group for severe COVID-19 disease and vaccination is key to reducing this risk. As immunosuppressed patients demonstrate an attenuated response to vaccination, the efficacy of a third primary dose followed by a subsequent booster is being investigated.

查看译文

关键词

COVID-19, glomerular disease, SARS-CoV-2, vaccination

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要